Formulation Flashcards
pH conversion & predominant form
pH = pKa —> HA = A- or B = BH+
I unit = 90.0%
2 units = 99.0%
3 units = 99.9%
(above = A- / B; below = HA / BH+)
Log D (at pH 7) in terms of solubility & absorption
Log D < 1 = too polar good solubility, poor absorption
Log D 1-3 = best balance between solubility & absorption
Log D > 3 = very non-polar, poor solubility
Intranasal characteristics
(Total volume, total surface area, dose, olfactory region)
Total volume = 15-20 mL
Total SA = 150 cm3
Dose = 100-150 micrometer
Olfactory region = 15 cm2
Lipinski’s rule of 5 (for nasal delivery)
- < 5 H bond donors
- < 10 H bond acceptors
- Molecular weight < 500 Da
- Log P < 5 & unionised
- Particle size > 10 micrometer
Nasal spray formulation considerations (5)
- Priming ( >7d = re-prime)
- Viscosity (higher = longer residence = bad)
- Particle size (smaller = travel further = good)
- Osmolarity (hypotonic 300-700 = better permeability)
- Spray pattern & plume geometry
Excipients for intranasal
(Solubility, permeation enhancer)
Solubility: Glycerol, PEG
Permeation enhancer: Fatty acid, cyclodextrin
Mass Median Aerodynamic diameter (MMAD)
MMAD > 10 = intranasal
5 > MMAD > 1 = therapeutic interest for aerosol (pulmonary)
Factors for aerosol deposition (6)
- Inertial impaction: Stokes < 1 = good
- Gravitation sedimentation & force: small particle + low density = good
- Velocity: lower = deeper in lung = good
- Buoyancy force: lower = suspended = good
- Drag force = lower = better
- Brownian diffusion = bigger = better
CNS Lipinski’s rule of 5
< 450 Da
H bond donor < 3
H bond acceptor < 7
Log P 1-3
Unionised
Suppository base amount equation
Amount of base = (number of suppository x Calibration value) - (number of suppository x drug amount / displacement value)
Displacement value equation
DV = Weight of drug / weight of base displaced by drug
Excipients list:
1. Diluent
2. Surfactant
3. Buffer
4. Preservatives
5. Co-solvents
6. Permeation enhancers
7. Suspending agents
8. Tonicity adjusters
9. Viscosity enhancers
- Diluent = lactose
- Surfactant = Polysorbate 80
- Buffer = sodium phosphate
- Preservatives = benzalkonium chloride
- Co-solvents = PEG
- Permeation enhancers = Oleic acid
- Suspending agents = MCC
- Tonicity adjusters = sodium Chloride
- Viscosity enhancers = CMC
Properties of Ideal Parenteral Formulations
- pH (IM: 3 - 11, SC: 3-6)
- Tonicity (280-290 mOsmol/L) for large vol parenterals - hypertonic is preferred
- No visible particles (more for IV than SC/IM)
Hydrophile-Lipophile-Balance (HLB) for Emulsifiers
Scale from 0 (Hydrophobic - oil soluble) to 18 (Hydrophilic - water soluble)
HLB > 10 –> o/w emulsion more likely to be formed